The invention discloses a new crystal of apatinib sulfate; the new crystal has an XRPD pattern having diffraction peaks at 2 theta values approximately: 3.681, 7.319, 10.96, 14.62, 15.54, 16.8, 17.62, 18.3, 18.699, 19.48, 20.74, 21.1, 21.58, 22.5, 23.159, 24.16, 24.7, 25.38, 26.779, 28.079, 28.5, 29.06, 29.979, 31.181, 33.28, and 35.42, wherein a 2 theta value error range is 0.2. The new crystal has the advantages that the obtained crystal A of apatinib sulfate has the stability superior to that of an amorphous form, has good solubility, and is conducive to preservation.